Market Closed

HLP
Hongli Group
$ 4.12
-7.00%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

Hongli Group News

Latest Hongli Group Stock News & HLP Headlines

Helus Pharma to Present Topline Results from Phase 3 APPROACH Study Evaluating HLP003 as Adjunctive Treatment in Major Depressive Disorder on November 16, 2026
12 hours ago | globenewswire.com
Hongli Group Provides Progress Update on Proposed Acquisition of a 20% Equity Interest in Xell Energy
17 days ago | prnewswire.com
Hongli Group Provides Strategic Update on Proposed Advanced Battery Collaboration as Xell Energy Achieves Drone Customer Design Wins
a month ago | prnewswire.com
Helus Pharma: A Buy Ahead Of The HLP003 Phase 3 Readout
a month ago | seekingalpha.com
Hongli Group Inc. Announces Appointment of Mr. Michael W.
a month ago | prnewswire.com
Helus Pharma Eyes Q4 Phase III Data for HLP-003 in Major Depression
2 months ago | marketbeat.com
Helus Pharma Presents New Analyses on HLP003 in Major Depressive Disorder at Psych Congress 2026
2 months ago | globenewswire.com
Helus Pharma: An Undervalued Psychedelic Platform Approaching A Major Catalyst
3 months ago | seekingalpha.com
Hongli Group Inc. Announces Compliance with Nasdaq Minimum Bid Price Requirement
3 months ago | prnewswire.com
Helus Pharma Completes Enrollment in Phase 3 APPROACH Study of HLP003 in Adjunctive Treatment of Major Depressive Disorder Ahead of Schedule
4 months ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

HLP
Hongli Group
$ 4.12
-7.00%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago